Key Financial Data Of Reporting Company

JCR Pharmaceuticals Co.,Ltd. - Filing #7295903

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2023-09-30
2023-04-01 to
2023-09-30
Key financial data of reporting company
Business results of reporting company
Net sales
16,657,000,000 JPY
42,871,000,000 JPY
24,272,000,000 JPY
Ordinary profit (loss)
-1,621,000,000 JPY
7,264,000,000 JPY
7,126,000,000 JPY
Net assets
57,049,000,000 JPY
56,475,000,000 JPY
57,125,000,000 JPY
Total assets
104,622,000,000 JPY
102,226,000,000 JPY
103,988,000,000 JPY
Basic earnings (loss) per share
-5.53
44.13
42.10
Diluted earnings per share
43.92
41.90
Equity-to-asset ratio
0.541 xbrli:pure
0.542 xbrli:pure
0.539 xbrli:pure
Net cash provided by (used in) operating activities
-1,109,000,000 JPY
9,312,000,000 JPY
3,521,000,000 JPY
Net cash provided by (used in) investing activities
-2,962,000,000 JPY
-2,690,000,000 JPY
-1,288,000,000 JPY
Net cash provided by (used in) financing activities
3,852,000,000 JPY
-2,031,000,000 JPY
-761,000,000 JPY
Cash and cash equivalents
18,271,000,000 JPY
18,756,000,000 JPY
15,968,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.